Alcon - Stock Price History | ALC

Historical daily share price chart and data for Alcon since 2022 adjusted for splits. The latest closing stock price for Alcon as of October 03, 2022 is 59.40.
  • The all-time high Alcon stock closing price was 88.50 on December 29, 2021.
  • The Alcon 52-week high stock price is 88.78, which is 49.5% above the current share price.
  • The Alcon 52-week low stock price is 56.18, which is 5.4% below the current share price.
  • The average Alcon stock price for the last 52 weeks is 75.40.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Alcon Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 75.4056 65.6800 88.5000 65.3200 87.1200 32.04%
2020 58.8945 56.3700 66.5700 39.8600 65.9800 16.63%
2019 58.6560 58.0400 63.3300 54.4300 56.5700 0.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $28.513B $8.291B
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $198.711B 20.24
Edwards Lifesciences (EW) United States $51.226B 36.24
STERIS (STE) Ireland $16.630B 20.66
Teleflex (TFX) United States $9.450B 15.06
Fresenius Medical Care AG KGaA (FMS) Germany $8.228B 7.59
Penumbra (PEN) United States $7.184B 861.82
Globus Medical (GMED) United States $5.928B 30.24
Glaukos (GKOS) United States $2.520B 0.00
Integer Holdings (ITGR) United States $2.061B 16.12
Nevro (NVRO) United States $1.649B 0.00
Paragon 28 (FNA) United States $1.368B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.031B 15.78
Artivion (AORT) United States $0.558B 53.23